DRESS (drug reaction with eosinophilia and systemic symptom) syndrome caused by both first-line and second-line antitubercular medications: A case report with a brief literature review
Allergy, Asthma & Respiratory Disease
;
: 111-116, 2017.
Article
in Korean
| WPRIM
| ID: wpr-161597
ABSTRACT
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but potentially fatal drug-induced systemic hypersensitivity response characterized by erythematous eruption, fever, leukocytosis with eosinophilia, and internal organ involvement. Antitubercular agents are potential causative agents for DRESS syndrome but difficult to verify as a culprit drug, since antitubercular agents are coadministered as a combination regimen. A 42-year-old female with endobronchial tuberculosis was diagnosed with DRESS syndrome after 4-week treatment of isoniazid, rifampicin, ethambutol, and pyrazinamide with prednisolone 50 mg. All the antitubercular agents were stopped and replaced with levofloxacin, cycloserine, p-aminosalicylic acid, and kanamycin. However, severe exacerbation of DRESS syndrome compelled the patient to discontinue the administration of the second-line antitubercular agents. Two months later, the patient underwent a patch test for all the antitubercular agents which had been used, and the results showed positivity to isoniazid and cycloserine. We report a rare case of DRESS syndrome that reacted to cycloserine as well as isoniazid. Development of coreactivity to other drugs should be differentiated with a flare-up reaction in the management of DRESS syndrome.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Aminosalicylic Acid
/
Pyrazinamide
/
Rifampin
/
Tuberculosis
/
Patch Tests
/
Prednisolone
/
Kanamycin
/
Cycloserine
/
Eosinophilia
/
Ethambutol
Type of study:
Diagnostic study
Limits:
Adult
/
Female
/
Humans
Language:
Korean
Journal:
Allergy, Asthma & Respiratory Disease
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS